Highline Wealth Partners
IBB icon

Highline Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

Highline Wealth Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$43.2K Hold
205
– – 0.01% 279
2026
Q2 		$39K Hold
205
– – 0.01% 271
2026
Q1 		$34.6K Sell
205
-25
-11% -$4.28K 0.01% 215
2025
Q4 		$38.8K Hold
230
– – 0.01% 156
2025
Q3 		$33.2K Hold
230
– – 0.01% 192
2025
Q2 		$29.1K Buy
230
+25
+12% +$3.07K 0.01% 175
2025
Q1 		$26.2K Hold
205
– – 0.01% 175
2024
Q4 		$27.1K Hold
205
– – 0.01% 161
2024
Q3 		$29.8K Sell
205
-106
-34% -$15.3K 0.01% 156
2024
Q2 		$42.7K Buy
311
+162
+109% +$21.6K 0.02% 133
2024
Q1 		$20.5K Buy
+149
New +$20.3K 0.01% 172

Other funds holding IBB

Albion Financial Group
Albion Financial Group Salt Lake City, Utah $1.77B AUM 14.95% 1-Year Est. Return
Generali Investments CEE
Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return
MinichMacGregor Wealth Management
MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return
Investment House LLC
Investment House LLC Redondo Beach, California $2.25B AUM 30.44% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
NTV Asset Management
NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return
Old National Bancorp
Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return
Redstone Wealth Management
Redstone Wealth Management Oklahoma City, Oklahoma $159M AUM 31.94% 1-Year Est. Return
Folger Nolan Fleming Douglas Capital Management
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.18B AUM 27.44% 1-Year Est. Return
Decker Retirement Planning
Decker Retirement Planning Levi, Utah $302M AUM 70.25% 1-Year Est. Return

Highline Wealth Partners's IBB Position: Q3 2026 in Review

Highline Wealth Partners held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 205 shares worth $43.2K. The position accounts for 0.01% of the portfolio, ranked #279.

Highline Wealth Partners first reported a position in IBB in Q1 2024 and has held it in 11 quarters since. 279 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Highline Wealth Partners held 205 shares of iShares Biotechnology ETF worth $43.2K as of Q3 2026.
  • Highline Wealth Partners left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up 0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #279 holding.
  • Highline Wealth Partners first reported a position in iShares Biotechnology ETF in Q1 2024 and has held it in 11 quarters since.
  • 279 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.